Compared with the previous year, the pharmaceutical group increased its revenue by 24%. The company allocated EUR9 million for investments in pharmacies, expansion in rural and urban areas, and staff training in 2026.
“The 2025 results confirm the strength of a business model built on two complementary pillars: retail, which is the foundation of the group’s operations, and logistics, where we have accelerated growth by entering new segments. (…),” said Eugen Banciu, Chairman of the Board of Directors of the Dona Group.
(English version by Loredana Fratila-Cristescu)